Effects of metformin on endometrial cancer cell growth in vivo: A preoperative prospective trial
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of metformin on endometrial cancer cell growth in vivo: A preoperative prospective trial
Authors
Keywords
-
Journal
CANCER
Volume 120, Issue 19, Pages 2986-2995
Publisher
Wiley
Online
2014-06-11
DOI
10.1002/cncr.28853
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin use and endometrial cancer survival
- (2013) Nicole S. Nevadunsky et al. GYNECOLOGIC ONCOLOGY
- Metformin is associated with improved survival in endometrial cancer
- (2013) Emily M. Ko et al. GYNECOLOGIC ONCOLOGY
- Repositioning metformin for cancer prevention and treatment
- (2013) Brendan J. Quinn et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study
- (2012) Saroj Niraula et al. BREAST CANCER RESEARCH AND TREATMENT
- Mortality After Incident Cancer in People With and Without Type 2 Diabetes: Impact of metformin on survival
- (2012) C. J. Currie et al. DIABETES CARE
- Insulin resistance and cancer: epidemiological evidence
- (2012) Manami Inoue et al. ENDOCRINE-RELATED CANCER
- Insulin resistance: A significant risk factor of endometrial cancer
- (2012) Nan Mu et al. GYNECOLOGIC ONCOLOGY
- Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial
- (2012) Bernardo Bonanni et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective evaluation of insulin resistance among endometrial cancer patients
- (2011) Jennifer K. Burzawa et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial
- (2011) Sirwan Hadad et al. BREAST CANCER RESEARCH AND TREATMENT
- Metformin induces unique biological and molecular responses in triple negative breast cancer cells
- (2011) Bolin Liu et al. CELL CYCLE
- Antidiabetic Drug Metformin Induces Apoptosis in Human MCF Breast Cancer via Targeting ERK Signaling
- (2011) Ahmed Malki et al. ONCOLOGY RESEARCH
- Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
- (2010) A. DeCensi et al. Cancer Prevention Research
- Metformin Prevents Tobacco Carcinogen-Induced Lung Tumorigenesis
- (2010) R. M. Memmott et al. Cancer Prevention Research
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
- (2010) Marc Foretz et al. JOURNAL OF CLINICAL INVESTIGATION
- Metformin is a potent inhibitor of endometrial cancer cell proliferation—implications for a novel treatment strategy
- (2009) Leigh A. Cantrell et al. GYNECOLOGIC ONCOLOGY
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
- (2009) Sao Jiralerspong et al. JOURNAL OF CLINICAL ONCOLOGY
- Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells
- (2008) Jingchun Gao et al. CANCER SCIENCE
- In vitro metformin anti-neoplastic activity in epithelial ovarian cancer
- (2008) Walter H. Gotlieb et al. GYNECOLOGIC ONCOLOGY
- The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
- (2008) I Ben Sahra et al. ONCOGENE
- Metformin induces apoptosis of pancreatic cancer cells
- (2008) Luo-Wei Wang et al. WORLD JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now